Two-season effectiveness of a single nirsevimab dose against RSV hospitalisation in healthy term-born infants: a population-based case-control study, Spain, October 2023 to March 2025. - Núñez O; Juaneda J; Martinez-Marcos M; Muñoz Platón E; Rivas Wagner E; Santiago-Pérez MI; Álvarez Río V; Zornoza Moreno M; Fernández Ibáñez A; Perez Suarez G; Loroño Ortiz G; Egüés N; et al. (Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2026)